eFFECTOR Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
eFFECTOR Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q1 2024.
  • eFFECTOR Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $749K, a 8.71% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.98M, a 21% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. annual Interest Expense for 2023 was $2.92M, a 29.7% increase from 2022.
  • eFFECTOR Therapeutics, Inc. annual Interest Expense for 2022 was $2.25M, a 27.6% increase from 2021.
  • eFFECTOR Therapeutics, Inc. annual Interest Expense for 2021 was $1.76M, a 32.3% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.98M $749K +$60K +8.71% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.92M $758K +$60K +8.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $2.86M $750K +$180K +31.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.68M $722K +$217K +43% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.46M $689K +$211K +44.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.25M $698K +$208K +42.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $2.04M $570K +$82K +16.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $1.96M $505K +$25K +5.21% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.94M $478K +$172K +56.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.76M $490K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $488K +$146K +42.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $480K +$140K +41.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $306K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $342K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $340K Apr 1, 2020 Jun 30, 2020 8-K 2021-08-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.